Compugen and Merck Serono Ventures to Jointly Establish New Biomarker Company Neviah Genomics Ltd

News   Jun 25, 2012

 
Compugen and Merck Serono Ventures to Jointly Establish New Biomarker Company Neviah Genomics Ltd
 
 
 
FURTHER INFORMATION
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE